Randomized phase II study of CPT-11 plus mitomycin C versus oxaliplatin plus mitomycin C in previously treated patients with advanced colorectal cancer (ACC)

Phase Ii Study ◽

Randomized Phase Ii ◽

A phase II study of milataxel: a novel taxane analogue in previously treated patients with advanced colorectal cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-007-0489-5 ◽

2007 ◽

Vol 61 (3) ◽

pp. 453-458 ◽

Cited By ~ 19

Author(s):

Ramesh K. Ramanathan ◽

Joel Picus ◽

Haralambos Raftopoulos ◽

Stephen Bernard ◽

A. Craig Lockhart ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Phase II Study of Pulse 5-Fluoro-2′-Deoxyuridine and Leucovorin in Advanced Colorectal Cancer Patients Previously Treated with Chemotherapy

American Journal of Clinical Oncology ◽

10.1097/00000421-199204000-00004 ◽

1992 ◽

Vol 15 (2) ◽

pp. 115-118 ◽

Cited By ~ 1

Author(s):

John C. Marsh ◽

Henry J. Durivage ◽

Carol Davis ◽

Kyle OʼHollaren ◽

Dominick N. Pasquale ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Previously Treated ◽

Colorectal Cancer Patients

Phase II study of biweekly irinotecan and mitomycin C combination therapy in patients with fluoropyrimidine-resistant advanced colorectal cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-003-0604-1 ◽

2003 ◽

Vol 52 (2) ◽

pp. 125-130 ◽

Cited By ~ 8

Author(s):

Tadamichi Denda ◽

Tomonori Ambo ◽

Atsushi Ohtsu ◽

Yasuhide Yamada ◽

Kuniaki Shirao ◽

...

Keyword(s):

Colorectal Cancer ◽

Combination Therapy ◽

Mitomycin C ◽

Phase Ii ◽

Phase Ii Study

Phase II Study of Personalized Peptide Vaccination for Previously Treated Advanced Colorectal Cancer

Cancer Immunology Research ◽

10.1158/2326-6066.cir-14-0035 ◽

2014 ◽

Vol 2 (12) ◽

pp. 1154-1162 ◽

Cited By ~ 37

Author(s):

Shiro Kibe ◽

Shigeru Yutani ◽

Satoru Motoyama ◽

Takanobu Nomura ◽

Natsuki Tanaka ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Peptide Vaccination ◽

Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomized phase II study

Annals of Oncology ◽

10.1093/annonc/mdp359 ◽

2010 ◽

Vol 21 (4) ◽

pp. 781-786 ◽

Cited By ~ 28

Author(s):

G. Rosati ◽

S. Cordio ◽

R. Bordonaro ◽

G. Caputo ◽

G. Novello ◽

...

Keyword(s):

Colorectal Cancer ◽

Elderly Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Randomized Phase Ii

Phase II study of capecitabine, oxaliplatin and erlotinib in previously treated patients with metastatic colorectal cancer (MCRC)

10.1200/jco.2004.22.14_suppl.3580 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3580-3580 ◽

Cited By ~ 7

Author(s):

J. A. Meyerhardt ◽

A. Xhu ◽

P. C. Enzinger ◽

D. P. Ryan ◽

J. W. Clark ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Activity of the combination of bevacizumab (Bev) with capecitabine/irinotecan (CapIri/Bev) or capecitabine/oxaliplatin (CapOx/Bev) in advanced colorectal cancer (ACRC): A randomized phase II study of the AIO Colorectal Study Group (AIO trial 0604)

10.1200/jco.2008.26.15_suppl.4030 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 4030-4030 ◽

Cited By ~ 25

Author(s):

A. C. Reinacher-Schick ◽

S. Kubicka ◽

W. Freier ◽

D. Arnold ◽

G. Dietrich ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Study Group ◽

Randomized Phase Ii

A randomized phase II study of biweekly irinotecan versus irinotecan plus 5-fluorouracil/leucovorin combination as a salvage chemotherapy in previously treated patients with advanced/metastatic gastric cancer.

10.1200/jco.2010.28.15_suppl.e14511 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e14511-e14511 ◽

Cited By ~ 1

Author(s):

S. Sym ◽

Y. Park ◽

S. Park ◽

J. Park ◽

E. Cho ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Gastric Cancer ◽

Salvage Chemotherapy ◽

Randomized Phase Ii ◽

Randomized phase II study of erlotinib (E) alone or combined with fulvestrant (F) in previously treated patients with advanced non-small cell lung cancer (NSCLC).

10.1200/jco.2010.28.15_suppl.tps295 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. TPS295-TPS295

Author(s):

E. B. Garon ◽

S. M. Dubinett ◽

W. Hosmer ◽

K. L. Reckamp ◽

F. F. Kabbinavar ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Randomized Phase Ii ◽

Biomarkers for immunotherapy: Results from the analysis of an HLA-status double-blind, biologically randomized phase II study of five therapeutic epitope-peptides with oxaliplatin-based chemotherapy as first-line therapy for advanced colorectal cancer (FXV study).

10.1200/jco.2014.32.15_suppl.3038 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 3038-3038

Author(s):

Shoichi Hazama ◽

Yusuke Nakamura ◽

Hiroaki Tanaka ◽

Ko Tahara ◽

Ryoichi Shimizu ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

First Line ◽

Double Blind ◽

First Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii